Page last updated: 2024-08-25

rosiglitazone and Uterine Neoplasms

rosiglitazone has been researched along with Uterine Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carson, DD; Engel, BJ1
Lan, SM; Li, CZ; Li, JF; Shi, M; Wang, F; Wang, YY; Wen, ZQ; Yang, GW; Zhang, CH; Zhang, H; Zhang, YJ; Zhu, Y1

Other Studies

2 other study(ies) available for rosiglitazone and Uterine Neoplasms

ArticleYear
Activated EGFR stimulates MUC1 expression in human uterine and pancreatic cancer cell lines.
    Journal of cellular biochemistry, 2013, Volume: 114, Issue:10

    Topics: Blotting, Western; Cell Line, Tumor; Epidermal Growth Factor; ErbB Receptors; Female; Gene Expression; Humans; Mucin-1; Pancreatic Neoplasms; Quinazolines; Rosiglitazone; Thiazolidinediones; Tyrphostins; Uterine Neoplasms

2013
Inhibition of proliferation and transforming growth factor beta3 protein expression by peroxisome proliferators-activated receptor gamma ligands in human uterine leiomyoma cells.
    Chinese medical journal, 2008, Jan-20, Volume: 121, Issue:2

    Topics: Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Leiomyoma; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta3; Uterine Neoplasms

2008